Investing.com – Denmark stocks were higher after the close on Monday, as gains in the Consumer Goods, Healthcare and Real Estate sectors led shares higher.
At the close in Copenhagen, the OMX Copenhagen 20 rose 0.98%.
The best performers of the session on the OMX Copenhagen 20 were Novozymes A/S B (CSE:NZYMb), which rose 2.42% or 8.40 points to trade at 355.10 at the close. Meanwhile, Chr Hansen Holding A/S (CSE:CHRH) added 1.43% or 7.10 points to end at 504.00 and Novo Nordisk A/S Class B (CSE:NOVOb) was up 1.43% or 13.60 points to 961.50 in late trade.
The worst performers of the session were Bavarian Nordic (CSE:BAVA), which fell 7.82% or 18.70 points to trade at 220.40 at the close. Ambu A/S (CSE:AMBUb) declined 1.18% or 1.14 points to end at 95.20 and GN Store Nord (CSE:GN) was down 0.93% or 1.65 points to 175.30.
Falling stocks outnumbered advancing ones on the Copenhagen Stock Exchange by 77 to 70 and 21 ended unchanged.
Crude oil for March delivery was down 0.83% or 0.66 to $79.02 a barrel. Elsewhere in commodities trading, Brent oil for delivery in April fell 0.98% or 0.85 to hit $85.55 a barrel, while the February Gold Futures contract fell 0.34% or 6.50 to trade at $1,922.90 a troy ounce.
USD/DKK was unchanged 0.03% to 6.84, while EUR/DKK unchanged 0.04% to 7.44.
The US Dollar Index Futures was up 0.15% at 101.88.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.